Tigers pitcher Al Alburquerque has changed agencies from ACES to Beverly Hills Sports Council, CBS Sports' Jon Heyman tweets. Major League Baseball investigates ACES' possible ties to the Biogenesis scandal. Alburquerque has pitched 71 innings in his big-league career, posting a 1.90 ERA with 16.3 K/9 and 8.2 BB/9. He has 14 1/3 innings pitched for the Tigers this year. Here are more notes from around the Majors.
- MLB's latest PED scandal could impact pennant races and the trading deadline, says ESPN.com's Jim Bowden (Insider-only). Teams don't know the identities of all the players in the Biogenesis scandal and who might be suspended as a result, Bowden writes, and that could make it difficult for GMs as they head down the stretch. Melky Cabrera's abrupt departure from the Giants last August — after the trading deadline — is the sort of scenario that might be faced by some GMs, who will have a hard time preparing for suspensions they might not be sure are coming. The Giants, of course, won the World Series even without Cabrera, but they didn't have one of their most productive hitters in the final six weeks of the regular season. This year, the Rangers, for example, will have to consider their backup plan in case Nelson Cruz, who has been named in the scandal, is suspended.
- The list of sellers at this year's trade deadline could be large, Ken Rosenthal of FOX Sports writes. Rosenthal's list of potential sellers includes three teams that entered the season with lofty aspirations (the Dodgers, Angels and Blue Jays), along with the Astros, Marlins, Phillies, Padres, Brewers, Cubs, White Sox, Twins, Royals, Mariners and Mets. That's a very long list, which suggests that it might be a buyer's market at the deadline. Rosenthal says, however, that some of those teams (the Angels, Blue Jays, Phillies and Royals, in particular) might not actually sell, even though some of their records right now might dictate that they would.
- Tsuyoshi Wada of the Orioles could agree to remain in the minor leagues once his rehab stint is over, reports MASN Sports' Roch Kubatko. Wada has not pitched well for Triple-A Norfolk, posting a 5.87 ERA in 23 innings, and after having elbow surgery, he has yet to make his big-league debut despite being in the second year of a two-year, $8.15MM deal. That deal hasn't worked out well, but Kubatko quotes a scout who says it made sense at the time. "[Wada] was worth the gamble. When he came in, (Miguel) Gonzalez wasn't there, (Wei-Yin) Chen wasn't established, (Jason) Hammel wasn't there yet. So he was worth the gamble. And it wasn't a lot of money."
- Jeff Francis will likely start on Saturday for the Rockies, but his future with the organization is in question, Patrick Saunders of the Denver Post writes. "I think I can help this team, and I think I can do a lot of things," says Francis. "But I know that the reality of baseball is that if you don’t do them enough, then your time runs out." Francis had posted a 6.00 ERA with 7.8 K/9 and 3.5 BB/9 before landing on the disabled list with a strained groin. Tyler Chatwood, who Francis will replace on Saturday, will still have his rotation spot when he returns from a sore triceps, and Roy Oswalt, currently at Double-A Tulsa, is slated to join the big-league team shortly.